Ziad Mirza

All filings by Ziad Mirza on record concern Innovus Pharmaceuticals, Inc. The record holds 7 filings, for trades running from 16 October 2013 to 2 January 2015.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

Most recently, on 6 January 2015, the filings show a share grant in Innovus Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.